A detailed history of Hnp Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hnp Capital LLC holds 14,094 shares of BMY stock, worth $692,438. This represents 0.27% of its overall portfolio holdings.

Number of Shares
14,094
Previous 14,110 0.11%
Holding current value
$692,438
Previous $1.02 Million 3.84%
% of portfolio
0.27%
Previous 0.29%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 18, 2023

SELL
$65.71 - $74.53 $1,051 - $1,192
-16 Reduced 0.11%
14,094 $976,000
Q4 2022

Jan 24, 2023

BUY
$68.48 - $81.09 $3,150 - $3,730
46 Added 0.33%
14,110 $0
Q3 2022

Oct 18, 2022

SELL
$0.13 - $76.84 $152 - $90,363
-1,176 Reduced 7.72%
14,064 $1 Million
Q2 2022

Jul 20, 2022

BUY
$72.62 - $79.98 $72,184 - $79,500
994 Added 6.98%
15,240 $1.17 Million
Q1 2022

Aug 15, 2022

SELL
$61.48 - $73.72 $1.56 Million - $1.86 Million
-25,296 Reduced 63.97%
14,246 $1.04 Million
Q1 2022

May 02, 2022

BUY
$61.48 - $73.72 $1.56 Million - $1.86 Million
25,296 Added 177.57%
39,542 $2.89 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $45,037 - $51,035
780 Added 5.79%
14,246 $884,000
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $29,289 - $32,456
-510 Reduced 3.65%
13,466 $859,000
Q2 2020

Jul 06, 2020

SELL
$54.82 - $64.09 $1.49 Million - $1.74 Million
-27,118 Reduced 65.99%
13,976 $827,000
Q1 2020

Apr 22, 2020

BUY
$46.4 - $67.43 $1.28 Million - $1.86 Million
27,528 Added 202.92%
41,094 $2.29 Million
Q4 2019

Jan 13, 2020

BUY
$49.21 - $64.19 $22,144 - $28,885
450 Added 3.43%
13,566 $885,000
Q3 2019

Oct 04, 2019

SELL
$42.77 - $50.71 $32,505 - $38,539
-760 Reduced 5.48%
13,116 $650,000
Q2 2019

Jul 16, 2019

SELL
$44.62 - $49.34 $669 - $740
-15 Reduced 0.11%
13,876 $629,000
Q1 2019

Apr 24, 2019

SELL
$45.12 - $53.8 $4,421 - $5,272
-98 Reduced 0.7%
13,891 $663,000
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $682,103 - $884,524
13,989 New
13,989 $727,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hnp Capital LLC Portfolio

Follow Hnp Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hnp Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hnp Capital LLC with notifications on news.